万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>中国国际期刊>>医学综合

创新·医学(英文)(The Innovation Medicine)(国际刊号)(OA期刊) (官网投稿)

简介
《创新·医学(英文)》(The Innovation Medicine)(季刊),创刊于2023年,是The Innovation的医学姊妹刊,通过开放获取(Open Access)的方式面向全球发表创新、严谨和前沿的重要医学研究进展。The Innovation Medicine由北京大学的乔杰院士担任主编。
本刊为:外文期刊,
征稿信息

万维提示:

1、该刊只有国际刊号!

2、投稿方式:在线投稿。

3、刊内网址:(202401期)

http://www.the-innovation.org/medicine

4、投稿系统:

https://mc03.manuscriptcentral.com/innovation-medicine

5、官网邮箱:medicine@the-innovation.org

6、出刊日期:季刊,逢季末月出版。

2024325日星期一

                        

 

Information for Authors作者指南

【官网信息】

 

Information for Authors

The Innovation Medicine is a sister journal of The Innovation. It is expected to influence clinical decision for both better patient care and better continuing medical education, aiming to have an impact in world health community. The Innovation Medicine is an international general medical journal via Open Access, publishing innovative, rigorous and cutting-edge progress in medical science, especially in multidisciplinary co-operation achievements. After publishing, your works will go to global reach and visibility, which is supposed to educate this journal’s audience.

Aims & Scope:  The Innovation Medicine welcome submission of original works from any branches of medicine that advance medical science or clinical practice, including but not limited to:

1. Aging

2. Basic medicine

3. Cardiovascular disease

4. Clinical trials (Phase 1, 2, 3 or 4)

5. Gene therapy or cell therapy or self-definition therapy

6. Global health issues

7. Human microbiome

8. Infectious diseases

9. Medical imaging

10. Medical immunology

11. Neurology and psychiatry

12. Oncology

13. Physiology and pathology

14. Public health study and policy

15. Regenerative medicine

16. Translational medicine

17. MedicineX (multidisciplinary collaboration): artificial intelligence in healthcare, smart wearable devices, et al.

Unique Features:

1. Open access and fair peer review (blocklist of unfair peers)

2. Short processing time from submission to first decision (regular <3 weeks, fast track <1 week)

3. Award given to reviewers (irrespective of paper decision) and Lead Contact (upon acceptance) in order to clearly demonstrate our support of scientific standards

4. Involvement by the Central Academy of Fine Arts in the quality of figures and charts

5. Use of social media (Facebook/Twitter/Instagram/WeChat) to promote papers

6. For APC information, please see our rights, sharing, and embargoes page.

……

更多详情:

http://www.the-innovation.org/medicine/authors


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭